Subtopic Deep Dive

Pathogenic vs Regulatory TH17 Cells
Research Guide

What is Pathogenic vs Regulatory TH17 Cells?

Pathogenic TH17 cells are pro-inflammatory effectors producing GM-CSF and IFNγ that drive autoimmune diseases like psoriasis, while regulatory TH17 cells secrete IL-10 to suppress inflammation.

Over 20 papers distinguish pathogenic TH17 subsets from regulatory ones based on cytokine profiles and developmental pathways. Key studies show IL-23 drives pathogenic TH17 cells (Langrish et al., 2005, 4011 citations), while TGF-β promotes regulatory T cell alternatives (Bettelli et al., 2006, 6831 citations). Human Th17 heterogeneity includes pathogenic and non-pathogenic subsets (Annunziato et al., 2007, 1827 citations).

15
Curated Papers
3
Key Challenges

Why It Matters

Distinguishing pathogenic TH17 cells enables psoriasis therapies targeting IL-23/IL-17 axis without broad immunosuppression, as shown in imiquimod mouse models (van der Fits et al., 2009, 2050 citations). Precision immunotherapy avoids depleting protective regulatory TH17 subsets, improving outcomes in autoimmune inflammation (Nestlé et al., 2009, 2693 citations). Targeting pathogenic effectors reduces skin lesions in IL-23-driven models (Langrish et al., 2005).

Key Research Challenges

Transcriptomic Profiling

Separating pathogenic GM-CSF+IFNγ+ TH17 from regulatory IL-10+ subsets requires single-cell RNA-seq to capture heterogeneity. Annunziato et al. (2007) identified human Th17 cytokine profiles but lacked plasticity data. Scalable markers for clinical distinction remain elusive.

Developmental Pathways

Reciprocal TGF-β and IL-6/IL-23 signals generate pathogenic vs regulatory TH17, but conversion mechanisms are unclear (Bettelli et al., 2006). Bettelli et al. (2006) showed Foxp3 inhibition of RORγt, yet psoriasis-specific triggers need mapping. Environmental cues driving plasticity challenge targeted therapies.

Psoriasis Model Validation

Imiquimod-induced models confirm IL-23/IL-17 mediation but may not fully replicate human pathogenic TH17 dominance (van der Fits et al., 2009). Translating mouse findings to human lesions requires better biomarkers (Nestlé et al., 2009).

Essential Papers

1.

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Estelle Bettelli, Yijun Carrier, Wenda Gao et al. · 2006 · Nature · 6.8K citations

2.

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

Claire L. Langrish, Yi Chen, Wendy M. Blumenschein et al. · 2005 · The Journal of Experimental Medicine · 4.0K citations

Interleukin (IL)-23 is a heterodimeric cytokine composed of a unique p19 subunit, and a common p40 subunit shared with IL-12. IL-12 is important for the development of T helper (Th)1 cells that are...

3.

Psoriasis

Frank O. Nestlé, Daniel H. Kaplan, Juliet N. Barker · 2009 · New England Journal of Medicine · 2.7K citations

4.

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

Leslie van der Fits, Sabine Mourits, Jane S.A. Voerman et al. · 2009 · The Journal of Immunology · 2.0K citations

Abstract Topical application of imiquimod (IMQ), a TLR7/8 ligand and potent immune activator, can induce and exacerbate psoriasis, a chronic inflammatory skin disorder. Recently, a crucial role was...

5.

Psoriasis Pathogenesis and Treatment

Adriana Rendón, Knut Schäkel · 2019 · International Journal of Molecular Sciences · 1.9K citations

Research on psoriasis pathogenesis has largely increased knowledge on skin biology in general. In the past 15 years, breakthroughs in the understanding of the pathogenesis of psoriasis have been tr...

6.

Phenotypic and functional features of human Th17 cells

Francesco Annunziato, Lorenzo Cosmi, Veronica Santarlasci et al. · 2007 · The Journal of Experimental Medicine · 1.8K citations

T helper (Th) 17 cells represent a novel subset of CD4+ T cells that are protective against extracellular microbes, but are responsible for autoimmune disorders in mice. However, their properties i...

7.

TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function

Liang Zhou, Jared E. Lopes, Mark M. W. Chong et al. · 2008 · Nature · 1.8K citations

Reading Guide

Foundational Papers

Start with Bettelli et al. (2006) for reciprocal TH17/Treg pathways and Langrish et al. (2005) for IL-23 pathogenic role, as they establish core mechanisms cited 10,000+ times total.

Recent Advances

Study Lowes et al. (2014, 1544 citations) for psoriasis immunology and Rendón & Schäkel (2019, 1884 citations) for updated pathogenesis linking TH17 to treatments.

Core Methods

Cytokine staining (Annunziato et al., 2007), IL-23 blockade models (van der Fits et al., 2009), TGF-β/RORγt signaling assays (Bettelli et al., 2006).

How PapersFlow Helps You Research Pathogenic vs Regulatory TH17 Cells

Discover & Search

PapersFlow's Research Agent uses searchPapers to find IL-23-driven TH17 papers like Langrish et al. (2005), then citationGraph reveals Bettelli et al. (2006) as a high-impact hub with 6831 citations, and findSimilarPapers expands to psoriasis models like van der Fits et al. (2009). exaSearch queries 'pathogenic TH17 psoriasis GM-CSF IFNγ' for 250M+ OpenAlex papers.

Analyze & Verify

Analysis Agent applies readPaperContent to extract cytokine profiles from Annunziato et al. (2007), verifies claims with CoVe against Nestlé et al. (2009), and runs PythonAnalysis on scRNA-seq data for differential expression stats between pathogenic and regulatory subsets, graded by GRADE for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in TH17 plasticity conversion, flags contradictions between mouse (Langrish et al., 2005) and human data (Annunziato et al., 2007); Writing Agent uses latexEditText for figure captions, latexSyncCitations to integrate 10 papers, and latexCompile for a review manuscript with exportMermaid diagrams of developmental pathways.

Use Cases

"Extract transcriptomic differences between pathogenic and regulatory TH17 cells from top papers"

Research Agent → searchPapers('pathogenic regulatory TH17 psoriasis') → Analysis Agent → runPythonAnalysis(pandas on cytokine data from Bettelli 2006, Annunziato 2007) → CSV of DEGs with stats.

"Draft LaTeX figure comparing TH17 pathways in psoriasis models"

Synthesis Agent → gap detection (IL-23 axis van der Fits 2009) → Writing Agent → latexGenerateFigure(mermaid TH17 diagram) → latexSyncCitations(Bettelli 2006, Langrish 2005) → latexCompile → PDF figure.

"Find code for TH17 single-cell analysis in psoriasis repos"

Research Agent → paperExtractUrls(Annunziato 2007) → Code Discovery → paperFindGithubRepo → githubRepoInspect(Seurat/Scanpy scripts) → runPythonAnalysis on repo data for GM-CSF markers.

Automated Workflows

Deep Research workflow scans 50+ TH17 papers via searchPapers → citationGraph → structured report on pathogenic vs regulatory ratios in psoriasis (Nestlé 2009). DeepScan's 7-step chain verifies IL-23 claims (Langrish 2005) with CoVe checkpoints and GRADE scoring. Theorizer generates hypotheses on TH17 plasticity from Bettelli (2006) and Annunziato (2007) abstracts.

Frequently Asked Questions

What defines pathogenic vs regulatory TH17 cells?

Pathogenic TH17 produce GM-CSF+IFNγ driving inflammation (Langrish et al., 2005); regulatory TH17 secrete IL-10 (Annunziato et al., 2007).

What methods study TH17 subsets?

Cytokine profiling, scRNA-seq, and imiquimod mouse models assess subsets (van der Fits et al., 2009; Bettelli et al., 2006).

What are key papers?

Bettelli et al. (2006, 6831 citations) on pathways; Langrish et al. (2005, 4011 citations) on IL-23; Annunziato et al. (2007) on human features.

What open problems exist?

Plasticity conversion markers and psoriasis-specific triggers lack definition (Nestlé et al., 2009).

Research Psoriasis: Treatment and Pathogenesis with AI

PapersFlow provides specialized AI tools for Immunology and Microbiology researchers. Here are the most relevant for this topic:

See how researchers in Life Sciences use PapersFlow

Field-specific workflows, example queries, and use cases.

Life Sciences Guide

Start Researching Pathogenic vs Regulatory TH17 Cells with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Immunology and Microbiology researchers